Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience
Mutualfunds logo

FBTIX Fidelity Advisor® Biotechnology I

  • Fund
  • FBTIX
  • Price as of: Dec 08, 2016
  • $21.82
  • + $0.07
  • + 0.32%
  • Category
  • Health & Biotech Equities

FBTIX - Profile

Vitals

  • YTD Return -20.5%
  • 3 Yr Annualized Return 6.9%
  • 5 Yr Annualized Return 23.0%
  • Net Assets $2.56 B
  • Holdings in Top 10 42.6%

52 WEEK LOW AND HIGH

$21.82
$18.21
$27.87

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.78%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 29.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

STANDARD (TAXABLE)

$2,500

IRA

$500

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -20.5%
  • 3 Yr Annualized Total Return 6.9%
  • 5 Yr Annualized Total Return 23.0%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -0.42%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name Fidelity Advisor® Biotechnology Fund
  • Fund Family Name Fidelity Investments
  • Inception Date Dec 27, 2000
  • Shares Outstanding N/A
  • Share Class Inst
  • Currency USD
  • Domiciled Country United States
  • Manager Rajiv Kaul

Fund Description

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

FBTIX - Performance

Return Ranking - Trailing

Period FBTIX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -20.5% -30.9% 7.4% 89.29% 5
1 Yr -19.7% -20.5% 18.4% 96.40% 5
3 Yr 6.9% * -7.5% 17.2% 62.96% 4
5 Yr 23.0% * 9.3% 23.7% 1.94% 1
10 Yr 13.3% * 6.1% 14.8% 5.05% 1

* Annualized


Return Ranking - Calendar

Period FBTIX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 6.2% -20.4% 13.8% 8.18% 1
2014 31.5% -5.9% 31.5% 0.91% 1
2013 63.6% 0.0% 65.2% 1.83% 1
2012 30.1% -5.3% 36.5% 4.85% 1
2011 18.8% -15.5% 18.8% 0.98% 1

Total Return Ranking - Trailing

Period FBTIX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -20.5% -23.4% 7.5% 91.89% 5
1 Yr -19.7% -24.5% 10.5% 95.45% 5
3 Yr 6.9% * -14.2% 16.4% 55.56% 3
5 Yr 23.0% * 9.1% 23.7% 1.94% 1
10 Yr 13.3% * 6.1% 14.8% 5.05% 1

* Annualized


Total Return Ranking - Calendar

Period FBTIX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 12.4% -16.6% 20.7% 20.18% 1
2014 38.6% -5.8% 55.3% 28.44% 2
2013 77.6% 0.0% 398.7% 45.37% 3
2012 53.6% -5.1% 475.8% 28.00% 2
2011 29.2% -10.2% 2296.2% 15.46% 1

NAV & Total Return History

FBTIX - Holdings

Filings data as of: Oct 31, 2016

Concentration Analysis

FBTIX Category Low Category High FBTIX % Rank Quintile
Net Assets 2.56 B 20.6 M 43.6 B 10.71% 2
Number of Holdings 242 31 345 2.68% 1
Net Assets in Top 10 1.09 B 9.47 M 20.9 B 10.71% 2
Weighting of Top 10 42.6% 21.8% 73.4% 16.07% 2

Top 10 Holdings

  1. Gilead Sciences Inc 2.45%
  2. Celgene Corp 6.62%
  3. Vertex Pharmaceuticals Inc 3.06%
  4. Alexion Pharmaceuticals Inc 6.57%
  5. Regeneron Pharmaceuticals Inc 6.07%
  6. Biomarin Pharmaceutical Inc 3.00%
  7. Biogen Inc 6.86%
  8. Incyte Corp 2.67%
  9. Amgen Inc 3.31%
  10. Seattle Genetics Inc 1.96%

Asset Allocation

Weighting Category Low Category High FBTIX % Rank Quintile
Stocks
91.81% 82.12% 102.29% 31.25% 5
Cash
8.14% 0.00% 16.35% 3.57% 1
Preferred Stocks
0.05% 0.00% 1.35% 3.57% 1
Other
0.00% -2.29% 2.33% 11.61% 4
Convertible Bonds
0.00% 0.00% 0.38% 3.57% 4
Bonds
0.00% 0.00% 1.91% 5.36% 4

Stock Sector Breakdown

Weighting Category Low Category High FBTIX % Rank Quintile
Healthcare
88.17% 13.15% 99.87% 28.57% 4
Financial Services
0.17% 0.00% 1.11% 3.57% 1
Technology
0.06% 0.00% 64.83% 25.00% 4
Utilities
0.00% 0.00% 1.10% 1.79% 4
Real Estate
0.00% 0.00% 1.97% 2.68% 4
Industrials
0.00% 0.00% 13.35% 14.29% 4
Energy
0.00% 0.00% 0.00% 0.89% 4
Communication Services
0.00% 0.00% 2.15% 1.79% 4
Consumer Defense
0.00% 0.00% 2.38% 11.61% 4
Consumer Cyclical
0.00% 0.00% 3.21% 6.25% 5
Basic Materials
0.00% 0.00% 4.92% 4.46% 4

Stock Geographic Breakdown

Weighting Category Low Category High FBTIX % Rank Quintile
US
86.01% 60.11% 99.87% 19.64% 3
Non US
5.80% 0.00% 42.18% 22.32% 4

FBTIX - Expenses

Operational Fees

FBTIX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 0.78% 0.10% 4.31% 65.18% 1
Management Fee 0.55% 0.08% 1.25% 16.96% 1
12b-1 Fee N/A 0.00% 1.00% N/A N/A
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

FBTIX Fees (% of AUM) Category Low Category High FBTIX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

FBTIX Fees (% of AUM) Category Low Category High FBTIX Rank Quintile
Max Redemption Fee 0.75% 0.75% 2.00% 6.82% 1

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTIX Fees (% of AUM) Category Low Category High FBTIX Rank Quintile
Turnover 29.00% 7.00% 249.00% 21.43% 2

FBTIX - Distributions

Dividend Yield Analysis

FBTIX Category Low Category High FBTIX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

FBTIX Category Low Category High Category Mode
Dividend Distribution Frequency None Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

FBTIX Category Low Category High FBTIX % Rank Quintile
Net Income Ratio -0.42% -2.22% 1.40% 37.50% 3

Capital Gain Distribution Analysis

FBTIX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

FBTIX - Managers

Rajiv Kaul

Manager

Start Date

Oct 12, 2005

Tenure

11.14

Tenure Rank

8.4%

Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.


Tenure Analysis

Category Low

0.0

Category High

19.2

Category Average

8.89

Category Mode

1.9